NVSEF Novartis AG

USD 96.51 0.83 0.867475
Icon

Novartis AG (NVSEF) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 96.51

+0.83 (+0.87)%

USD 208.48B

320.00

N/A

N/A

Icon

NVSEF

Novartis AG (USD)
COMMON STOCK | OTC
USD 96.51
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 208.48B

N/A

USD 96.51

Novartis AG (NVSEF) Stock Forecast

N/A

Based on the Novartis AG stock forecast from 0 analysts, the average analyst target price for Novartis AG is not available over the next 12 months. Novartis AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Novartis AG is Slightly Bearish, which is based on 5 positive signals and 7 negative signals. At the last closing, Novartis AG’s stock price was USD 96.51. Novartis AG’s stock price has changed by +0.12% over the past week, -8.09% over the past month and +30.86% over the last year.

No recent analyst target price found for Novartis AG
No recent average analyst rating found for Novartis AG

Company Overview Novartis AG

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience...Read More

https://www.novartis.com

Lichtstrasse 35, Basel, Switzerland, 4056

76,057

December

USD

USA

Adjusted Closing Price for Novartis AG (NVSEF)

Loading...

Unadjusted Closing Price for Novartis AG (NVSEF)

Loading...

Share Trading Volume for Novartis AG Shares

Loading...

Compare Performance of Novartis AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NVSEF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Novartis AG (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AZNCF
AstraZeneca PLC +2.26 (+1.67%) USD206.87B 34.74 17.02

ETFs Containing NVSEF

Symbol Name NVSEF's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Novartis AG (NVSEF) Stock

Stock Target Advisor's fundamental analysis for Novartis AG's stock is Slightly Bearish.

NVSEF stock's dividend yield is 3.67%. Our analysis grades NVSEF stock's dividend yield at F. This means that NVSEF stock's dividend yield is above 57% of the stocks in the Drug Manufacturers - General sector in the OTC exchange. Based on this NVSEF may be a average dividend stock for its sector.

Unfortunately we do not have enough data on NVSEF's stock to indicate what its average analyst target is.

NVSEF stock's Price/Earning ratio is 24.88. Our analysis grades NVSEF stock's Price / Earning ratio at F. This means that NVSEF stock's Price/Earning ratio is above 47% of the stocks in the Drug Manufacturers - General sector in the OTC exchange. Based on this NVSEF may be fairly valued for its sector

The last closing price of NVSEF's stock was USD 96.51.

The most recent market capitalization for NVSEF is USD 208.48B.

Unfortunately we do not have enough analyst data on NVSEF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Novartis AG's stock.

As per our most recent records Novartis AG has 76,057 Employees.

Novartis AG's registered address is Lichtstrasse 35, Basel, Switzerland, 4056. You can get more information about it from Novartis AG's website at https://www.novartis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...